Karl Hård

Karl Hård

Investor Relations Contact at EGETIS THERAPEUTICS AB

Net worth: 92 042 $ as of 2026-06-29

64 year
Health Technology
Consumer Services

Profile

Karl J.
Hård
is currently VP-Investor Relations & Business Development at Egetis Therapeutics AB since 2022.
Former positions include Investor Relations Contact at AstraZeneca PLC, Assistant Professor at the University of Leiden, Head-Investor Relations & Corporate Communications at Redx Pharma Plc from 2016 to 2017, and Head-Investor Relations & Communications at Kiadis Pharma NV from 2017 to 2018.
Education includes a doctorate from the University of Utrecht and graduate studies at the University of Helsinki.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-30 150,982 ( 0.03% ) 92 042 $ 2026-06-29

Karl Hård active positions

CompaniesPositionStart
EGETIS THERAPEUTICS AB Investor Relations Contact 2022-01-31

Former positions of Karl Hård

CompaniesPositionEnd
KIADIS PHARMA N.V. Investor Relations Contact 2018-12-30
REDX PHARMA LTD Investor Relations Contact 2017-07-01
Corporate Officer/Principal -
ASTRAZENECA PLC Public Communications Contact -
See the detail of Karl Hård's experience

Training of Karl Hård

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

13

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology